Healthcare -
Biotechnology - NASDAQ - US
$ 17.37
-0.934 %
$ 2.18 B
Market Cap
-11.27
P/E
APLS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities APLS - Apellis Pharmaceuticals, Inc.
-403 K
LAST VALUE
-0.34%
2 YEAR CAGR
24.96%
5 YEAR CAGR
-35.07%
10 YEAR CAGR